1) 125 I-UdR
125I-脱氧尿嘧啶核苷
1.
Objective It is to investigate the pharmic safety and curative effect of 125 I-UdR in athymic mouse model bearing bladder cancer for the preparation of clinic application of 125 I-UdR.
目的研究125I-脱氧尿嘧啶核苷(125I-UdR)在荷人膀胱癌裸鼠移植瘤模型中的应用效果和安全性,为125I-UdR临床应用提供实验依据。
2) ~(125)I UdR
125I脱氧尿嘧啶核苷
3) uracil deoxyriboside
尿嘧啶脱氧核苷
4) BrdU
5-溴脱氧尿嘧啶核苷
1.
Technical explore on mesenchymal stem cells in bone marrow using BrdU labelling;
5-溴脱氧尿嘧啶核苷标记骨髓间充质干细胞的技术探讨
2.
Objective To study the feasibility of labeling adipose-derived adult stem cells with BrdU.
目的探讨5-溴脱氧尿嘧啶核苷(BrdU)标记脂肪成体干细胞(adipose-derived adult stem cells,ADASCs)的可行性。
3.
AIM: To study the differentiation characteristics and the optimal dosage and timing for bromodeoxyuridine (Brdu) labeling of rat bone marrow-derived mesenchymal stem cells (MSCs) in vitro.
目的:探讨骨髓间充质干细胞(MSCs)在体外的诱导分化及5-溴脱氧尿嘧啶核苷(Brdu)标记MSCs的可行性。
5) bromodeoxyuridine
['brəuməudi,ɔksi'juəridi:n]
溴脱氧尿嘧啶核苷
1.
A study on the proliferation of oral cancer cell labelling using bromodeoxyuridine;
溴脱氧尿嘧啶核苷掺入标记口腔肿瘤的研究
2.
Apoptosis in gastric signet ring cell carcinomas induced by intermittent administration of bromodeoxyuridine;
目的 给带癌实验犬间歇性注射溴脱氧尿嘧啶核苷(BrdU)至49 h,观察BrdU诱发印戒细胞癌发生的凋亡变化。
6) floxuridine
氟尿嘧啶脱氧核苷
1.
To study the therapeutic effect of chemotherapy with carboplatin and floxuridine combined with radiotherapy for advanced esophageal carcinoma.
［目的］探讨卡铂加氟尿嘧啶脱氧核苷配合放射治疗中晚期食管癌的疗效。
2.
To analyse the efficacy of the floxuridine(FUDR)-containing regime (single agent or in combination)in the treatment of gestational trophoblastic tumor.
目的探讨氟尿嘧啶脱氧核苷(floxuridine,FUDR)单药、联合方案治疗妊娠滋养细胞肿瘤患者的疗效。
补充资料：[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式：C16H16ClN3O3S
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
分子量：365.5
CAS号：26807-65-8
性质：暂无
制备方法：暂无
用途：用于轻、中度原发性高血压。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条